Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Welcure Drugs & Pharmaceuticals Limited (WELCURE.BO)

Compare
8.54
+0.40
+(4.91%)
At close: 3:28:26 PM GMT+5:30
Loading Chart for WELCURE.BO
  • Previous Close 8.14
  • Open 8.31
  • Bid 8.53 x --
  • Ask 8.54 x --
  • Day's Range 7.74 - 8.54
  • 52 Week Range 6.40 - 12.83
  • Volume 58,771
  • Avg. Volume 36,949
  • Market Cap (intraday) 960.852M
  • Beta (5Y Monthly) -1.11
  • PE Ratio (TTM) 53.38
  • EPS (TTM) 0.16
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Welcure Drugs & Pharmaceuticals Limited does not have significant operations. Previously, it was engaged in the wholesale of pharmaceutical and medical products in India. The company was incorporated in 1992 and is based in Delhi, India.

welcuredrugs.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: WELCURE.BO

View More

Performance Overview: WELCURE.BO

Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

WELCURE.BO
26.82%
S&P BSE SENSEX (^BSESN)
1.40%

1-Year Return

WELCURE.BO
30.46%
S&P BSE SENSEX (^BSESN)
5.62%

3-Year Return

WELCURE.BO
30.46%
S&P BSE SENSEX (^BSESN)
32.06%

5-Year Return

WELCURE.BO
30.46%
S&P BSE SENSEX (^BSESN)
151.76%

Compare To: WELCURE.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WELCURE.BO

View More

Valuation Measures

Annual
As of 4/15/2025
  • Market Cap

    915.85M

  • Enterprise Value

    913.58M

  • Trailing P/E

    51.85

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.14

  • Price/Book (mrq)

    0.90

  • Enterprise Value/Revenue

    2.74

  • Enterprise Value/EBITDA

    37.73

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.66%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    333.88M

  • Net Income Avi to Common (ttm)

    18.89M

  • Diluted EPS (ttm)

    0.16

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.27M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: WELCURE.BO

View More

Company Insights: WELCURE.BO

Research Reports: WELCURE.BO

View More

People Also Watch